Limerick BioPharma's Unattributed Round

Limerick BioPharma raised a round of funding on January 30, 2012.

Limerick BioPharma is developing compounds that per the company when used adjunctively with both marketed and investigational drugs improve drug side effect profiles and clinical outcomes. By activati…

Articles about Limerick BioPharma's Unattributed Round: